Skip to main content

June 10: VDP Formulary, CAD, MCO Search Realignment Now Active

Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2024. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed December 12, 2024.
  2. IMB Micromedex DRUGDEX (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed December 12, 2024.
  3. Azilsartan tablets (Edarbi) package insert. Azurity Pharmaceuticals, Inc., January 2024.
  4. Candesartan tablets (Atacand) package insert. ANI Pharmaceuticals, Inc., June 2020.
  5. Irbesartan tablets (Avapro) package insert. Sanofi-Aventis U.S., September 2021.
  6. Losartan tablets (Cozaar) package insert. Organon, October 2021.
  7. Olmesartan tablets (Benicar) package insert. Cosette Pharmaceuticals, Inc., February 2022.
  8. Telmisartan tablets (Micardis) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., December 2022.
  9. Valsartan tablets (Diovan) package insert. Novartis Pharmaceuticals Corporation, April 2021.
  10. Valsartan oral solution package insert. ANI Pharmaceuticals, Inc., September 2023.
  11. Losartan/hydrochlorothiazide tablets (Hyzaar) package insert. Organon, March 2023.
  12. Sacubitril/valsartan tablets (Entresto) package insert. Novartis Pharmaceuticals Corporation, April 2024.
  13. Amlodipine/Olmesartan tablets (Azor) package insert. Cosette Pharmaceuticals, Inc., February 2022.
  14. Amlodipine/valsartan tablets (Exforge) package insert. Novartis Pharmaceuticals Corporation, April 2021.
  15. Amlodipine/valsartan/hydrochlorothiazide tablets (Exforge HCT) package insert. Novartis Pharmaceuticals Corportation, February 2021.
  16. Azilsartan/chlorthalidone tablets (Edarbyclor) package insert. Arbor Pharmaceuticals, July 2022.
  17. Candesartan/hydrochlorothiazide tablets (Atacand HCT) package insert. ANI Pharmaceuticals, Inc., May 2020.
  18. Irbesartan/hydrochlorothiazide tablets (Avalide) package insert. Sanofi-Aventis U.S., July 2023.
  19. Olmesartan/amlodipine/hydrochlorothiazide tablets (Tribenzor) package insert. Cosette Pharmaceuticals, Inc., February 2022.
  20. Olmesartan/hydrochlorothiazide tablets (Benicar HCT) package insert. Cosette Pharmaceuticals, Inc., February 2022.
  21. Telmisartan/amlodipine tablets package insert. Alembic Pharmaceuticals, Limited., January 2023.
  22. Telmisartan/hydrochlorothiazide tablets (Micardis HCT) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., December 2022.
  23. Valsartan/hydrochlorothiazide tablets (Diovan HCT) package insert. Novartis Pharmaceuticals Corporation, August 2020.
  24. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-59.
  25. Phillips CO, Kashani A, Ko DK, et al. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction. A quantitative review of data from randomized clinical trials. Arch Intern Med. 2007;167:1930-6.
  26. Heidenreich P, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022 May, 79 (17) e263–e421. 
  27. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71:e127-e248.
  28. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-e228.